← Back to Search

Behavioural Intervention

Intervention ExerciseRx-MS for Fatigue

N/A
Recruiting
Led By Dawn Ehde, PhD
Research Sponsored by University of Washington
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 18 or older
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, weeks 13 and 26
Awards & highlights

Study Summary

This trial aims to test if a phone app can help patients with multiple sclerosis who don't exercise much to become more active.

Who is the study for?
This trial is for adults over 18 with Multiple Sclerosis who can walk without help but are not very active (less than 150 minutes of exercise per week). They must have an iPhone or Android phone to use the study app and cannot be at high risk of falling or have other conditions that make exercising unsafe.Check my eligibility
What is being tested?
The study tests a phone-based app called ExerciseRx designed to increase physical activity in people with MS. Participants will use this app, which aims to promote more movement through personalized guidance and tracking.See study design
What are the potential side effects?
Since the intervention involves increased physical activity, potential side effects may include muscle soreness, fatigue, and an increased risk of falls for those predisposed. However, individuals at higher fall risk are excluded from the trial.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, weeks 13 and 26
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, weeks 13 and 26 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Physical activity: daily average step count
Secondary outcome measures
Activity volume
Depressive symptom severity - PROMIS Depression Short Form 8a
Fatigue - PROMIS Fatigue-MS Short Form 8a
+7 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention ExerciseRx-MSExperimental Treatment1 Intervention
Participants use the ExerciseRx app to meet personalized daily step targets and weekly goals. They will receive MS Exercise and Physical Activity Recommendations and complete in-app surveys about barriers to being active and physical activity level. The ExerciseRx app will adjust the personalized step count goals based on percentage met of the previous week goal and providers will send supportive messages based on participant activity. Participants will complete validated self-report assessments. Providers may also provide participants with additional guidance, make referrals, or schedule telemedicine or in-person clinic follow ups if needed to support the participant's physical activity progression.
Group II: Usual careActive Control1 Intervention
Participants receive MS Exercise and Physical Activity Recommendations, will continue typical physical activity, and complete validated self-report assessments. At the end of 26 weeks, staff will offer the participants the ExerciseRx intervention protocol.

Find a Location

Who is running the clinical trial?

University of WashingtonLead Sponsor
1,741 Previous Clinical Trials
1,847,660 Total Patients Enrolled
9 Trials studying Fatigue
1,010 Patients Enrolled for Fatigue
Dawn Ehde, PhDPrincipal InvestigatorUW Medicine
3 Previous Clinical Trials
447 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research study currently accepting new participants?

"As per clinicaltrials.gov, this particular research endeavor is not currently open for enrollment. Initially shared on 2/16/2024 and last revised on 2/13/2024, the study has since concluded its recruitment phase. Nonetheless, it's worth noting that amidst the numerous ongoing trials, there are presently 824 opportunities available for potential participants to consider."

Answered by AI
~71 spots leftby Apr 2025